You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Tobramycin, Dexamethasone Drug Combination

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hepatitis B, Infectious Disease, Liver Diseases Trial in Tempe, Lincoln, San Antonio (CRV431, Placebo, TDF)

Completed
  • Hepatitis B
  • +2 more
  • Tempe, Arizona
  • +2 more
Nov 30, 2021

Covid19 Trial in Rochester (Placebo, Fisetin)

Enrolling by invitation
  • Covid19
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 17, 2022

HIV Trial in United States (PRO 140 (350 mg), PRO 140 (525 mg), PRO 140 (700 mg))

Active, not recruiting
  • HIV
  • PRO 140 (350 mg)
  • +2 more
  • La Mesa, California
  • +11 more
Jan 13, 2022

Critical Illness, Starvation Trial in Hasselt, Leuven (Withholding PN during the first week of ICU stay, Oliclinomel N71000 OR

Active, not recruiting
  • Critical Illness
  • Starvation
  • Withholding PN during the first week of ICU stay
  • Oliclinomel N71000 OR N71000E // Clinimix N17G35 OR N17G35E
  • Hasselt, Belgium
  • +2 more
Mar 8, 2022

Opioid-use Disorder, Addiction, Depression Trial in United States (Collaborative care Plus)

Not yet recruiting
  • Opioid-use Disorder
  • +4 more
  • Collaborative care Plus
  • Los Angeles, California
  • +11 more
May 3, 2022

Dry Eye Syndrome Trial in Seoul (SA001 Low dose, SA001 Mid dose, SA001 High dose)

Completed
  • Dry Eye Syndrome
  • SA001 Low dose
  • +3 more
  • Seoul, Korea, Republic of
    Seoul St. Mary's Hospital
Mar 4, 2022

Type2 Diabetes Trial in Amsterdam (EMPA/LINA 10/5 mg QD (n=22), LINA/EMPA 5/10 mg QD (N=22), Gliclazide 30 mg QD/BID (N=22))

Active, not recruiting
  • Type2 Diabetes
  • EMPA/LINA 10/5 mg QD (n=22)
  • +2 more
  • Amsterdam, Noord-Holland, Netherlands
    VU University Medical Center
Jan 13, 2022

Renal Cell Carcinoma, Ovarian Carcinoma, Thyroid Carcinoma Trial in Groningen (Olaparib, Lenvatinib, Sunitinib)

Not yet recruiting
  • Renal Cell Carcinoma
  • +4 more
  • Groningen, Netherlands
    University Medical Center Groningen
Jul 13, 2023

Triple-negative Breast Cancer Trial in Beijing (KN046, Nab-paclitaxel)

Active, not recruiting
  • Triple-negative Breast Cancer
  • Beijing, Beijing, China
    National Cancer Center/Cancer Hospital, Chinese Academy of Medic
Nov 16, 2021

Moderate to Severe Calcified Coronary Artery Stenosis Trial (T-wave coronary lithotripsy catheter system)

Not yet recruiting
  • Moderate to Severe Calcified Coronary Artery Stenosis
  • T-wave coronary lithotripsy catheter system
  • (no location specified)
Dec 21, 2022

Knee Prosthesis Trial in Marseille (Thrombotic risk assessment)

Not yet recruiting
  • Knee Prosthesis
  • Thrombotic risk assessment
  • Marseille, Bouches Du Rhône, France
    Assistance Publique Hopitaux de Marseille
Aug 12, 2022

Triple-negative Breast Cancer Trial in Changsha, Nanjing (SKB264, KL-A167)

Not yet recruiting
  • Triple-negative Breast Cancer
  • Changsha, Hunan, China
  • +1 more
Jun 30, 2022

Safety Issues Trial in Taichung (Tenofovir Alafenamide 25 MG)

Recruiting
  • Safety Issues
  • Tenofovir Alafenamide 25 MG
  • Taichung, Taiwan
    Taichung Veterans General Hospital
Jun 9, 2022

Acute Myocardial Infarction Trial in Korea, Republic of (Hearticellgram-AMI)

Recruiting
  • Acute Myocardial Infarction
  • Hearticellgram-AMI
  • Chuncheon, Korea, Republic of
  • +9 more
Oct 21, 2021

Pain Trial in Kuala Lumpur (Oxycodone)

Completed
  • Pain
  • Kuala Lumpur, Wilayah Persekutuan, Malaysia
    Faculty of Medicine, University of Malaya
Jan 12, 2022

Osteosarcoma, Ewing Sarcoma, Rhabdomyosarcoma Trial in Washington (Cryoablation Therapy, Nivolumab, Ipilimumab)

Recruiting
  • Osteosarcoma
  • +9 more
  • Cryoablation Therapy
  • +2 more
  • Washington, District of Columbia
    Children's National Hospital
Mar 21, 2022

Chronic Lower Back Pain Trial in Rochester (Manual Therapy, Mind Body Intervention)

Completed
  • Chronic Lower Back Pain
  • Manual Therapy
  • Mind Body Intervention
  • Rochester, New York
    Rochester Outpatient Clinic
Mar 29, 2022

Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Jacksonville (Belantamab Mafodotin, Biospecimen

Not yet recruiting
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Belantamab Mafodotin
  • +6 more
  • Jacksonville, Florida
    Mayo Clinic in Florida
Apr 27, 2023

Gastric Cancer, Gastroesophageal Junction Cancer Trial in Worldwide (BBI608, Paclitaxel, Placebo)

Completed
Has Results
  • Gastric Cancer
  • Gastroesophageal Junction Cancer
  • Scottsdale, Arizona
  • +262 more
Apr 4, 2022

Pancreatic Cancer Trial in New Orleans, Dallas (XB2001 or Placebo)

Recruiting
  • Pancreatic Cancer
  • XB2001 or Placebo
  • Tucson, Arizona
  • +27 more
Jan 27, 2023

Patients Who Receive Colonoscopy Trial in Japan (NPF-08 (1-day treatment), NPF-08 (2-day split dose), Moviprep(1-day treatment))

Completed
  • Patients Who Receive Colonoscopy
  • NPF-08 （1-day treatment）
  • +2 more
  • Abiko, Chiba, Japan
  • +12 more
Nov 27, 2022

Advanced/Metastatic Solid Tumors or Lymphomas Trial in United States (ADU-S100, ipilimumab)

Terminated
  • Advanced/Metastatic Solid Tumors or Lymphomas
  • Aurora, Colorado
  • +6 more
Dec 10, 2021

Recurrent Brain Metastases, Progressive Brain Metastases Trial in United States (Meclofenamate)

Active, not recruiting
  • Recurrent Brain Metastases
  • Progressive Brain Metastases
  • Miami, Florida
  • +6 more
May 4, 2022

EGF-R Positive NSCLC, Non Small Cell Lung Cancer, EGFR Exon 19 Deletion Trial in Bogotá (Stereotactic Body Radiation Therapy

Not yet recruiting
  • EGF-R Positive Non-Small Cell Lung Cancer
  • +4 more
  • Stereotactic Body Radiation Therapy SBRT
  • Bogotá, Colombia
    CTIC - Centro de Tratamiento e Investigación Sobre Cáncer Luis C
Aug 16, 2023

Hypertension Trial in Mtubatuba (Community Health Worker Care Model, Enhanced Community Health Worker-based with Mobile Health

Not yet recruiting
  • Hypertension
  • Community Health Worker Care Model
  • +2 more
  • Mtubatuba, KwaZulu-Natal, South Africa
    Africa Health Research Institute (AHRI)
Aug 5, 2022